These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 17909261

  • 1. 18F-FDG PET in detecting primary breast cancer.
    Kumar R, Lal N, Alavi A.
    J Nucl Med; 2007 Oct; 48(10):1751; author reply 1752. PubMed ID: 17909261
    [No Abstract] [Full Text] [Related]

  • 2. Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets.
    Moy L, Ponzo F, Noz ME, Maguire GQ, Murphy-Walcott AD, Deans AE, Kitazono MT, Travascio L, Kramer EL.
    J Nucl Med; 2007 Apr; 48(4):528-37. PubMed ID: 17401088
    [Abstract] [Full Text] [Related]

  • 3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 4. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 Dec; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

  • 5. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007 Dec; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 6. Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers.
    Gaeta CM, Vercher-Conejero JL, Sher AC, Kohan A, Rubbert C, Avril N.
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):352-66. PubMed ID: 24322792
    [Abstract] [Full Text] [Related]

  • 7. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT.
    J Clin Oncol; 2006 Sep 20; 24(27):4371-6. PubMed ID: 16983105
    [Abstract] [Full Text] [Related]

  • 8. Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?
    Bitencourt AG, Lima EN, Chojniak R, Marques EF, Souza JA, Andrade WP, Guimarães MD.
    Eur J Radiol; 2014 Aug 20; 83(8):1381-6. PubMed ID: 24931922
    [Abstract] [Full Text] [Related]

  • 9. 18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed?
    Nguyen NQ, Bartholomeusz DF.
    J Gastroenterol Hepatol; 2011 Apr 20; 26(4):613-5. PubMed ID: 21418296
    [No Abstract] [Full Text] [Related]

  • 10. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.
    Acta Radiol; 2015 Aug 20; 56(8):917-23. PubMed ID: 25013091
    [Abstract] [Full Text] [Related]

  • 11. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct 20; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 12. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
    Landheer ML, Steffens MG, Klinkenbijl JH, Westenberg AH, Oyen WJ.
    Br J Surg; 2005 Nov 20; 92(11):1363-7. PubMed ID: 16187254
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep 20; 49(3):259-66. PubMed ID: 16172572
    [Abstract] [Full Text] [Related]

  • 14. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.
    Eur J Radiol; 2014 Feb 20; 83(2):289-96. PubMed ID: 24331845
    [Abstract] [Full Text] [Related]

  • 15. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
    Kim SY, Roh JL, Kim JS, Ryu CH, Lee JH, Cho KJ, Choi SH, Nam SY.
    Eur J Surg Oncol; 2008 Feb 20; 34(2):208-15. PubMed ID: 17482789
    [Abstract] [Full Text] [Related]

  • 16. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease.
    Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, Vondran F, Plotkin M, Stöver B, Henze G, Lemke AJ, Amthauer H.
    J Pediatr Hematol Oncol; 2006 Aug 20; 28(8):501-12. PubMed ID: 16912590
    [Abstract] [Full Text] [Related]

  • 17. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD, Carlson ER, Heidel RE.
    J Oral Maxillofac Surg; 2015 Jul 20; 73(7):1420-8. PubMed ID: 25869746
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2013 May 20; 49(5):449-53. PubMed ID: 23321549
    [Abstract] [Full Text] [Related]

  • 19. Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.
    Buchbender C, Herbrik M, Treffert J, Forsting M, Bockisch A, Antoch G, Heusner TA.
    Expert Rev Med Devices; 2012 May 20; 9(3):241-7. PubMed ID: 22702254
    [Abstract] [Full Text] [Related]

  • 20. F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging.
    Avril N, Adler LP.
    Radiol Clin North Am; 2007 Jul 20; 45(4):645-57, vi. PubMed ID: 17706529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.